We bridge INNOVATION with TRANSLATION
SINAPSE is changing the way that benchtop discovery is being taken into the clinic.
Originally founded as the Singapore Institute for Neurotechnology at the National University of Singapore, SINAPSE has since expanded its scope to address pressing needs in areas such as N-of-1 medicine, digital health and therapeutics, augmented cognition and training, and robotics, among other areas.
The core objective of our R+D program is clear:
The first-in-human deployment of interventional, Institute-driven technologies.
This objective has led to 10 ongoing/approved clinical studies.
These studies have resulted in life-saving outcomes.